Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
摘要:
Inhibition of soluble epoxide hydrolase (sEH) is hypothesized to lead to an increase in circulating levels of epoxyeicosatrienoic acids, resulting in the potentiation of their in vivo pharmacological properties. As part of all effort to identify inhibitors of sEH with high and sustained plasma exposure, we recently performed a high throughput screen of our compound collection, The screen identified N-(3,3-diphenylpropyl)-nicotinamide as a potent inhibitor of sEH. Further profiling of this lead revealed short metabolic half-lives in microsomes and rapid clearance in the rat. Consistent with these observations, the determination of the in vitro metabolic profile of N-(3,3-diphenyl-propyl)-nicotinamide in rat liver microsomes revealed extensive oxidative metabolism and a propensity for metabolite switching. Lead optimization, guided by the analysis of the solid-state costructure of N-(3,3-diphenyl-propyl)-nicotinamide bound to human sEH, led to the identification of a class of potent and selective inhibitors. An inhibitor from this class displayed an attractive in vitro metabolic profile and high and sustained plasma exposure in the rat after oral administration.
Coordinating activation strategy enables 1,2-alkylamidation of alkynes
作者:Jing Ren、Junhua Xu、Xiangxiang Kong、Jinlong Li、Kaizhi Li
DOI:10.1039/d3sc03786j
日期:——
The radical 1,2-difunctional alkylamidation of alkynes has been developed with the help of a bidentate coordinating group for the synthesis of β-alkylated enamides.
在双齿配位基团的帮助下,开发了炔烃的 1,2-二官能团烷基酰胺化作用,用于合成 β-烷基化烯酰胺。
Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
作者:Anne B. Eldrup、Fariba Soleymanzadeh、Steven J. Taylor、Ingo Muegge、Neil A. Farrow、David Joseph、Keith McKellop、Chuk C. Man、Alison Kukulka、Stéphane De Lombaert
DOI:10.1021/jm9005302
日期:2009.10.8
Inhibition of soluble epoxide hydrolase (sEH) is hypothesized to lead to an increase in circulating levels of epoxyeicosatrienoic acids, resulting in the potentiation of their in vivo pharmacological properties. As part of all effort to identify inhibitors of sEH with high and sustained plasma exposure, we recently performed a high throughput screen of our compound collection, The screen identified N-(3,3-diphenylpropyl)-nicotinamide as a potent inhibitor of sEH. Further profiling of this lead revealed short metabolic half-lives in microsomes and rapid clearance in the rat. Consistent with these observations, the determination of the in vitro metabolic profile of N-(3,3-diphenyl-propyl)-nicotinamide in rat liver microsomes revealed extensive oxidative metabolism and a propensity for metabolite switching. Lead optimization, guided by the analysis of the solid-state costructure of N-(3,3-diphenyl-propyl)-nicotinamide bound to human sEH, led to the identification of a class of potent and selective inhibitors. An inhibitor from this class displayed an attractive in vitro metabolic profile and high and sustained plasma exposure in the rat after oral administration.
Copper-Catalyzed 1,2-Difunctionalization Trifluoromethylamidation of Alkynes Assisted by a Coordinating Group
作者:Jing Ren、Kaiyun Liu、Ning Wang、Xiangxiang Kong、Jinlong Li、Kaizhi Li
DOI:10.1021/acscatal.3c02662
日期:2023.8.18
amenable for late-stage functionalization of natural compounds and biologically relevant motifs, allowing a straightforward synthesis of a large library of CF3-containing enamides, the high-value pharmacophores, in a single step from readily accessible amides, Langlois’ reagent, and alkynes. The current methodology can also be successfully extended to difluoromethylamidation of alkynes. Additionally